DIALYSIS - TRANSPLANTATION Left ventricular mass monitoring in the follow-up of dialysis patients: Prognostic value of left ventricular hypertrophy progression

Zoccali, Carmine; Benedetto, Francesco A.; Mallamaci, Francesca; Tripepi, Giovanni; Giacone, Giuseppe; Stancanelli, Benedetta; Cataliotti, Alessandro; Malatino, Lorenzo S.
April 2004
Kidney International;Apr2004, Vol. 65 Issue 4, p1492
Academic Journal
Left ventricular mass monitoring in the follow-up of dialysis patients: Prognostic value of left ventricular hypertrophy progression. Background. Regression of left ventricular hypertrophy (LVH) in the setting of a well-planned intervention study has been associated with longer survival in hemodialysis patients. Whether changes in left ventricular mass (LVM) in clinical practice predict survival and cardiovascular events in these patients is still unknown. Methods. In a prospective study in 161 hemodialysis patients we tested the prognostic value of changes in LVM on survival and incident cardiovascular events. Echocardiography was performed twice, 18 ± 2 SD months apart. Changes in LVM occurring between the first and the second echocardiographic study were then used to predict mortality and cardiovascular events during the ensuing 29 ± 13 months. The prognostic value of LVM changes was tested in a multivariate Cox's model with LVM index (LVMI) (expressed as LVM/height2.71), included as a covariate to control for regression to the mean. Results. The rate of increase of LVMI was significantly ( P= 0.029) higher in patients with incident cardiovascular events than in those without such events. Accordingly, cardiovascular event-free survival in patients with changes in LVMI below the 25th percentile was significantly ( P= 0.004) higher than in those with changes above the 75th percentile. In a multiple Cox regression analysis, including age, diabetes, smoking, homocysteine, 1 g/m2.7/month increase in LVMI was associated with a 62% increase in the incident risk of fatal and nonfatal cardiovascular events [hazard ratio 1.62 (95% CI 1.13–2.33), P= 0.009]. Conclusion. Changes in LVMI have an independent prognostic value for cardiovascular events and provide scientific support to the use of repeated echocardiographic studies for monitoring cardiovascular risk in dialysis patients.


Related Articles

  • Association between hypervolemia and ventricular hypertrophy in hemodialysis patients. Martin, L.C.; Franco, R.J.S.; Gavras, I.; Matsubara, B.B.; Garcia, S.; Caramori, J.T.; Barretti, B.B.; Balbi, A.L.; Barsanti, R.; Padovani, C.; Gavras, H. // American Journal of Hypertension;Dec2004, Vol. 17 Issue 12, p1163 

    Background: Left ventricular hypertrophy (LVH) is a well-known predictor of cardiovascular mortality in patients who have end-stage renal disease and are maintained on hemodialysis (HD), and LVH is not always correlated with the severity of hypertension in these patients. The purpose of this...

  • Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients. Mallamaci, Francesca; Zoccali, Carmine; Parlongo, Saverio; Tripepi, Giovanni; Benedetto, Francesco A.; Cutrupi, Sebastiano; Bonanno, Grazia; Fatuzzo, Pasquale; Rapisarda, Francesco; Seminara, Giuseppe; Stancanelli, Benedetta; Bellanuova, Ignazio; Cataliotti, Alessando; Malatino, Lorenzo S. // Kidney International;Nov2002, Vol. 62 Issue 5, p1884 

    Background. Cardiac troponin T (cTnT) is related to left ventricular (LV) mass in patients with end-stage renal disease (ESRD). Furthermore, cTnT reflects the severity of systolic dysfunction in patients with heart diseases. We tested the diagnostic value of cTnT for left ventricular hypertrophy...

  • Cardiovascular morbidity and mortality in patients treated with hemodialysis -- epidemiological analysis. Petrovic, Dejan; Stojimirovic, Biljana // Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journ;Dec2008, Vol. 65 Issue 12, p893 

    Background/Aim. Cardiovascular diseases are the leading cause of death in patients treated with hemodialysis (HD). The annual cardiovascular mortality rate in these patients is 9%. Left ventricular (LV) hypertrophy, ischemic heart disease and heart failure are the most prevalent cardiovascular...

  • LEFT VENTRICULAR HYPERTROPHY. Das, Bhagwan; Ansari, Rafique; Kumar, Santosh; Memon, Shafique-ur-Rehman // Professional Medical Journal;2015, Vol. 22 Issue 9, p1132 

    Cardiovascular system diseases are playing the outstanding role in the cause of morbidity and mortality in dialysis patients. Left ventricular hypertrophy is one of the universal structural abnormalities in patients on regular dialysis. Objective: The target of the study was to search out the...

  • Increased Survival with Long, Slow Hemodialysis.  // Kidney;Nov/Dec99, Vol. 8 Issue 6, p250 

    Compares the survival of patients receiving long, slow dialysis with the survival of those receiving 'conventional' dialysis. Increase in overall survival in patients receiving long, slow dialysis, which is seen not only in the most favorable prognostic categories but also in patients with...

  • Effect of on-line conductivity plasma ultrafiltrate kinetic modeling on cardiovascular stability of hemodialysis patients. Locatelli, Francesco; Andrulli, Simeone; Di Filippo, Salvatorre; Redaelli, Bruno; Mangano, Stefano; Navino, Carlo; Ariano, Rosario; Tagliaferri, Marco; Fidelio, Tommaso; Corti, Mauro; Civardi, Silvia; Tetta, Ciro // Kidney International;Apr1998, Vol. 53 Issue 4, p1052 

    Examines the effect of on-line conductivity plasma ultrafiltrate kinetic modeling on cardiovascular stability of hemodialysis patients. Conduction of the modified hemodiafiltration technique; Use of fixed dialysate conductivity; Improvement of intradialytic cardiovascular stability.

  • Left Ventricular Diastolic Function in a Predialysis Patient Population. Arodiwe, E. B.; Ulasi, I. I.; Ijoma, C. K.; Ike, S. O. // West African Journal of Medicine;Jul2010, Vol. 29 Issue 4, p225 

    BACKGROUND: Diastolic dysfunction is common in chronic kidney disease (CKD) accounting for 40%-66% of cardiovascular complications. OBJECTIVE: To determine the prevalence of and factors associated with left ventricular diastolic dysfunction (LVDD) in adult Nigerians with CKD at presentation and...

  • Additive Interaction of Metabolic Syndrome and Chronic Kidney Disease on Cardiac Hypertrophy, and Risk of Cardiovascular Disease in Hypertension. Iwashima, Yoshio; Horio, Takeshi; Kamide, Kei; Tokudome, Takeshi; Yoshihara, Fumiki; Nakamura, Satoko; Ogihara, Toshio; Rakugi, Hiromi; Kawano, Yuhei // American Journal of Hypertension;Mar2010, Vol. 23 Issue 3, p290 

    BackgroundRecent epidemiologic analyses have demonstrated a link between the metabolic syndrome (MetS) and chronic kidney disease (CKD). We examined the association between MetS, CKD, and left ventricular hypertrophy (LVH), and prospectively investigated the predictive value of the combination...

  • Intensive Control of BP and Anemia Recommended for Chronic HD Patients.  // Kidney;Jan/Feb98, Vol. 7 Issue 1, p26 

    Identifies risk factors for left ventricular hypertrophy (LVH) in chronic hemodialysis patients. Positive correlation of left ventricular mass index (VMI) to age, systolic blood pressure, and interdialytic weight gain; Factors with negative correlation to VMI.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics